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Hematological shift in goat kids
naturally devoid of prion protein
Malin R. Reiten, Maren K. Bakkebø, Hege Brun-Hansen, Anna M. Lewandowska-Sabat,
Ingrid Olsaker, Michael A. Tranulis, Arild Espenes* and Preben Boysen
Faculty of Veterinary Medicine and Biosciences, Norwegian University of Life Sciences, Oslo, Norway
The physiological role of the cellular prion protein (PrPC) is incompletely understood.
The expression of PrPC in hematopoietic stem cells and immune cells suggests a role
in the development of these cells, and in PrPC knockout animals altered immune cell
proliferation and phagocytic function have been observed. Recently, a spontaneous
nonsense mutation at codon 32 in the PRNP gene in goats of the Norwegian Dairy
breed was discovered, rendering homozygous animals devoid of PrPC. Here we report
hematological and immunological analyses of homozygous goat kids lacking PrPC
(PRNPTer/Ter ) compared to heterozygous (PRNP+/Ter) and normal (PRNP+/+) kids. Levels
of cell surface PrPC and PRNP mRNA in peripheral blood mononuclear cells (PBMCs)
correlated well and were very low in PRNPTer/Ter, intermediate in PRNP+/Ter and high
in PRNP+/+ kids. The PRNPTer/Ter animals had a shift in blood cell composition with
an elevated number of red blood cells (RBCs) and a tendency toward a smaller mean
RBC volume (P = 0.08) and an increased number of neutrophils (P = 0.068), all values
within the reference ranges. Morphological investigations of blood smears and bone
marrow imprints did not reveal irregularities. Studies of relative composition of PBMCs,
phagocytic ability of monocytes and T-cell proliferation revealed no significant differences
between the genotypes. Our data suggest that PrPC has a role in bone marrow
physiology and warrant further studies of PrPC in erythroid and immune cell progenitors
as well as differentiated effector cells also under stressful conditions. Altogether, this
genetically unmanipulated PrPC-free animal model represents a unique opportunity to
unveil the enigmatic physiology and function of PrPC.
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Introduction
The cellular prion protein (PrPC) was first described as the substrate for PrP scrapie (PrPSc)
(Prusiner, 1982; Brandner et al., 1996a,b), a misfolded and aggregation-prone form of the protein
detected in brain tissue of animals diagnosed with transmissible spongiform encephalopathies,
now often called prion diseases. These are fatal neurodegenerative diseases occurring naturally in
humans and ruminants and include Creutzfeldt-Jakob disease, bovine spongiform encephalopathy,
scrapie, and chronic wasting disease. The process of template-directed self-replication of PrPSc
constitutes the core of the “protein only” hypothesis (Prusiner et al., 1998), stating that the prion
agent consists solely of misfolded PrPC conformers, and in accordance with this, PrPC knock-out
(KO) mice do not replicate prions, nor do they develop prion disease (Bueler et al., 1992).
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PrPC is a highly conserved GPI-anchored protein (Steele et al.,
2007) expressed abundantly in the central nervous system (CNS)
(Kretzschmar et al., 1986), but also at lower levels in many other
cells like hematopoietic (Zhang et al., 2006) and embryonic stem
cells (Miranda et al., 2011), immune cells (Isaacs et al., 2006)
and various epithelial cell types (Horiuchi et al., 1995; Ford
et al., 2002), suggesting that PrPC might have important functions
within these cell types (Bendheim et al., 1992). In view of this,
it was puzzling that PrPC KO mice developed normally without
overt phenotypic abnormalities (Bueler et al., 1992; Manson
et al., 1994). Subsequent analyses have; however, revealed various
phenotypes such as altered circadian rhythms (Tobler et al.,
1996), behavior abnormalities (Roesler et al., 1999; Massimino
et al., 2013), increased susceptibility to oxidative stress (Wong
et al., 2001), and increased excitability of neurons (Khosravani
et al., 2008).
In bone marrow, PrPC is expressed in long-term
hematopoietic stem cells (Dodelet and Cashman, 1998; Zhang
et al., 2006) and may contribute to maintenance of stem cell
properties, since bone marrow stem cells derived from PrPC
KO mice, contrary to similar cells from wild-type mice, fail
to repopulate the bone marrow of irradiated recipient mice,
especially after serial transplantations (Zhang et al., 2006).
Interestingly, the PrPC expression in immune cells is regulated
according to their lineage fate. The observation that PrPC
expression is maintained at a high level in mononuclear cell
precursors and downregulated in granulocytic and erythroid
cells during their maturation in the bone marrow suggests that
PrPC plays a role in the dynamic development of these cells
(Dodelet and Cashman, 1998). PrPC is upregulated in activated
T lymphocytes (Mabbott et al., 1997) and neutrophils (Mariante
et al., 2012) and has been suggested to act as a signaling molecule
in the activation of immune cells (Mattei et al., 2004; Krebs et al.,
2006), but the definite role of PrPC in these processes remains
unclear.
Whether PrPC modulates macrophage functions, in particular
phagocytic capacity is controversial. Peritoneal macrophages
devoid of PrPC displayed increased phagocytosis toward
apoptotic cells in comparison with wild-type macrophages (De
Almeida et al., 2005), suggesting that PrPC acts as a negative
modulator of phagocytosis. Similar results were recently reported
in a study using primary cell culture of bone marrow-derived
macrophages from ZrchI type PrPC KOmice in comparison with
similar cells derived from C57BL/6 mice (Wang et al., 2014),
where the PrPC-depleted macrophages displayed increased
phagocytic capacity toward fluorescently labeled E. coli, enhanced
phagosome maturation and cytokine expression. Uraki and co-
workers; however, reached the opposite conclusion when using
immortalized bone marrow-derived macrophages from ZrchI
type PrPC KO mice, observing that loss of PrPC reduced
phagocytic capacity toward fluorescent latex beads (Uraki et al.,
2010).
Likewise, the proliferative response of T cells in vitro
upon cytokine stimulation has been studied in cells from
transgenicmice and cattle with andwithout PrPC. Murine studies
demonstrated a reduced proliferative response (Mabbott et al.,
1997) and altered cytokine profile (Bainbridge andWalker, 2005)
in Concanavalin A (Con A)-stimulated T cells from PrPC KO
mice indicating a role for PrPC in T-cell pathways leading to
proliferation. Data from transgenic PrPC KO cattle (Richt et al.,
2007) revealed no differences in the proliferative response of
T cells when stimulated with anti-CD3 antibody, Con A and
phytohemagglutinin. A further clarification of PrPC’s roles in
stem cell and immune cell maturation and function is desirable
and will be helpful in understanding PrPC’s functions in general.
Recently, a unique line of otherwise healthy Norwegian dairy
goats carrying a nonsense mutation at codon 32 (premature
termination codon, Ter) in the PRNP reading frame was
discovered (Benestad et al., 2012). The mutation results in an
early termination of PrPC synthesis and consequently animals
homozygous for this mutation are devoid of PrPC. This is, to our
knowledge, the first species identified that is naturally devoid of
PrPC. These animals are genetically unmanipulated and therefore
represent a unique spontaneous animalmodel to complement the
transgenic models available for studies of PrPC functions.
Here, we report results of hematological and immunological
analyses of goat kids without PrPC expression (PRNPTer/Ter)
compared to heterozygotes (PRNP+/Ter) and normal (PRNP+/+)
goats.
Methods
Animals and Sampling
The animals included in this study were of the Norwegian
Dairy Goat Breed obtained from a research herd of around 100
animals at the Norwegian University of Life Sciences. Based
on daily monitoring and enhanced health surveillance through
a national goat health monitoring service, the health status
of this flock is considered to be very good. Scrapie outbreaks
have never occurred and there have been no cases of caprine
arthritis encephalitis, Johne’s disease or caseous lymphadenitis
during the last 5 years (i.e., diseases subject to surveillance and
control program in Norway) (Nagel-Alne et al., 2014). The entire
flock was previously analyzed for PRNP genotypes (Benestad
et al., 2012) and through selective breeding goat kids with the
desired PRNPTer/Ter genotypes were retrieved. No animals died
of disease during the observation time and all PRNPTer/Ter
offspring developed normally during their first 6 months with no
signs of behavioral or health problems. The Norwegian Animal
Research Authority approved the protocol with reference to the
Norwegian regulation on animal experimentation (FOR-1996-
01-15-23, § 2) which is based upon the European Convention for
the Protection of Vertebrate Animals used for Experimental and
Other Scientific Purposes.
Blood was drawn from the jugular vein into heparinized tubes
and tubes without anticoagulant from age matched goat kids
at 3–4 weeks of age. For hematological and clinical chemistry
analyses, goat kids carrying the genotypes PRNPTer/Ter (n = 8),
PRNP+/Ter (n = 16), and PRNP+/+ (n = 24) were included.
Hematological analyses were performed with an Advia R©
2120 Hematology System using Advia 2120 MultiSpecies
System Software and clinical chemistry analyses were performed
with Advia 1800 Chemistry System (both from Siemens AG
Healthcare Sector).
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Peripheral blood mononuclear cells (PBMCs) were isolated
from PRNPTer/Ter (n = 8) and PRNP+/+ (n = 8) goat kids
by gradient centrifugation (Lymphoprep, Axis-Shield) at 1760 ×
g. Red blood cells (RBC) were lysed by brief exposure to sterile
water prior to counting and trypan blue viability assessment
using a Countess Automated Cell Counter (Life Technologies).
Morphology
For morphological studies, two age-matched male kids, one
PRNPTer/Ter and one PRNP+/+, were necropsied at 3 months of
age. Macroscopic examinations were performed routinely. Fresh
bonemarrow imprints and smears were made and evaluated after
staining with May Grünewald Giemsa. Histological slides were
prepared from formalin fixed and paraffin-embedded tissues and
stained with hematoxylin and eosin (HE) prior to examination by
light microscopy.
Real-time RT-PCR Analysis
Total RNA was isolated from PBMCs using the Qiagen RNeasy
mini plus kit (Qiagen) following the manufacturer’s instructions.
RNA concentration and purity was analyzed using NanoDrop-
1000 Spectrophotometer (Thermo Fisher Scientific), and quality
was assessed using RNA Nano Chips on an Agilent 2100
Bioanalyzer (both from Agilent Technologies). RNA was stored
at −80◦C. cDNA was synthesized using the SuperScript III
Reverse Transcriptase, RNase Out, dNTP mix and Random
Primers (all from Invitrogen, Life Technologies) at the following
conditions: 5min at 65◦C, >1min on ice, 5min at 25◦C, 1 h at
50◦C, and 15min at 70◦C.
Quantitative-PCR was conducted with LightCycler 480 Sybr
Green I Master mix (Roche), with PRNP as target gene (F:
GTG GCT ACA TGC TGG GAA GT; R: AGC CTG GGA TTC
TCT CTG GT) and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) as reference gene (F: GGT TGT CTC CTG CGA
CTT CA; R: TGG AAA TGT GTG GAG GTC GG). cDNA
corresponding to 1 ng RNA was used per reaction. The samples
had a total volume of 20µl, and were run on a LightCycler 480
System (Roche). Conditions: 5min at 95◦C; 40 cycles of 10 s at
95◦C, 10 s at 60◦C, and 10 s at 72◦C; and melting curve with 5 s
at 95◦C, 1min at 65 and 97◦C. Relative expression levels were
calculated using an externally run standard curve for the PBMCs
generated from one PRNP+/+ animal, run in duplicates, with one
randomly selected PRNP+/+ as positive control (in-run).
Flow Cytometry for Cell Surface PrP and Immune
Cell Markers
Immunophenotyping in flow cytometry was performed as
previously described (Olsen et al., 2013). Briefly, isolated PBMCs,
or whole blood if indicated, were incubated with Fixable
Yellow Dead Cell Stain Kit (Life Technologies, Thermo Fisher
Scientific Inc.) followed by primary monoclonal antibodies
(mAbs), brief incubation with 30% normal goat serum to
block Fc-receptors, and finally fluorescence-labeled goat-anti-
mouse secondary antibodies (see Supplementary Table 1). To
detect the intracellular CD3 epitope, surface-labeled cells were
permeabilized with Intracellular Fixation and Permeabilization
Buffer Set (eBioscience, Affymetrix Inc.) according to the
manufacturer’s instructions. Labeled cells were analyzed in
a Gallios flow cytometer and data were processed using
Kaluza 1.2 software (both Beckman Coulter, Inc.). Cell gates
were designed to select for single and viable mononuclear
cells.
Lymphocyte Proliferation Test
PBMCs were incubated in a flat-bottom 96 well plate for
72 h in complete medium with a density of 2 × 105 cells
per well. Cells were stimulated with Concanavalin A (ConA;
Sigma-Aldrich) (200µg/ml), recombinant ovine interleukin (IL)-
2 (10,000U/ml) (Connelley et al., 2011) or recombinant human
(rh)IL-15 (Affymetrix/eBioscience) (25,000U/ml). Unstimulated
cells were used as controls. Each treatment was run in three
to six parallels. Proliferation was measured as 24 h uptake
of 3H-thymidine (Perkin-Elmer, Waltham, USA) as previously
described (Storset et al., 2001) in counts per minute (CPM).
Parallels outside ±50% of the median were excluded, and net
proliferation (net CPM) was calculated as mean of stimulated
cells minus mean of unstimulated cells.
Isolation of Monocytes and Phagocytosis Assays
CD14+ monocytes were positively selected from isolated PBMCs
by anti-human CD14 MACS MicroBeads (Miltenyi Biotec
GmbH, Bergisch Gladbach, Germany) using 10µl beads per
107 cells. The purity was consistently measured between 90 and
95% by flow cytometry using anti-CD14mAbs (TUK4; IgG2a;
AbD Serotec). CD14+ monocytes were seeded in a 96 well non-
adherent plate (Corning Costar Ultra-Low Attachment multiwell
plates) in complete medium [RPMI+ 10% fetal calf serum (FCS)
+ 1% Penicillin/Streptomycin; Gibco] at 2 × 105 cells per well
and incubated for 24 h at 37◦C and 5% CO2 in the presence of
5000U/ml recombinant bovine granulocyte macrophage colony
stimulating factor (rbGM-CSF) that had been expressed in
293T cells as described (Lund et al., 2012) based on a btGM-
CSF plasmid (kindly provided by D. Werling, RVC, UK). The
resulting activated monocytes were incubated with latex beads
(FluoroSpheres 430/465, 20µl corresponding to 4 × 106 beads,
20 beads/cell, Life Technologies), pHrodo red E. coli or pHrodo
red Zymosan (both from Life Technologies) in separate wells.
Phagocytosis was terminated after 30min of incubation (37◦C,
5% CO2) by placing the plate on ice. The particle uptake was
measured in a Gallios flow cytometer. The monocyte gate was
adjusted to exclude free particles using cell-free particle-only
samples as control.
To confirm that the particles had been phagocytized,
monocytes were centrifuged onto slides at 1000 rpm for 5min.
The cells were fixed in acetone, blocked with goat serum
and immunolabeled with mAb against human CD68 (Dako).
The cytospots were incubated with secondary antibodies, Alexa
488 goat-anti-mouse IgG1 or Alexa 594 goat-anti-mouse IgG1,
mounted in Prolong Gold Antifade reagent with DAPI (all from
Life Technologies) and analyzed by standard fluorescence and
confocal microscopy.
Statistical Analysis
All data was analyzed for statistical significance with the Mann-
Whitney test and data reported with medians. A level of P < 0.05
was considered statistically significant and shown as ∗ and ∗∗
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in figures. GraphPad prism version 6.04 software was used for
statistical analyses.
Results
Expression of PrPC in Leukocytes Correlates
with Genotype
The absence of PrPC on PBMCs from PRNPTer/Ter goats was
confirmed by three different anti-PrPC mAbs (Figure 1A and
data not shown). The fluorescence intensity of anti-PrPC-stained
PBMCs showed that cells from PRNP+/Ter goats expressed
approximately half the density of surface PrPC as compared to
those from PRNP+/+ goats. When co-staining for immune cell
subpopulations, this pattern of PrPC expression was similar in
monocytes (CD14+), B cells (B-B2+), and T cells (CD3+) (data
not shown). Anti-PrPC mAbs staining of whole blood revealed
that PrPC was not expressed on the surface of granulocytes in
goats of either genotype, while its presence was confirmed in the
lymphocyte gate in PRNP+/+ goats (Figure 1B).
To investigate whether reduced PrPC levels in PRNP+/Ter and
PRNPTer/Ter animals would lead to compensatory upregulation
of PRNP mRNA, relative mRNA expression levels in PBMCs
and bone marrow were analyzed. As shown in Figures 1C,D,
the PRNP mRNA expression level in PBMCs from PRNPTer/Ter
animals was 16.8% of the expression in PRNP+/+ animals,
whereas the expression level in PRNP+/Ter PBMCs was 42.4%
of the PRNP+/+ animals. In the bone marrow, the relative
PRNP mRNA expression in the PRNPTer/Ter goat was 34% of the
PRNP+/+ goat investigated (Figure 1D). Collectively, these data
indicate that no compensatory mechanism is counteracting loss
of PrPC at PRNP mRNA expression level and that PRNPTer/Ter-
encoding mRNA is degraded.
FIGURE 1 | (A–D) Relative PrPC expression and PRNP mRNA
expression in PBMCs. (A) Representative plot of PrPC expression on
PBMCs is shown using anti-PrPC mAb BAR224. (B) Whole blood
analysis showing gating of live cells into granulocyte and lymphocyte
populations based on FS and SS characteristics. The two rightmost
plots show representative PrPC expression on lymphocytes and
granulocytes in PRNP+/+ (n = 6) and PRNPTer/Ter (n = 2) animals.
(C) Relative PRNP mRNA expression in PBMCs (each genotype
n = 8). (D) Relative PRNP mRNA expression in bone marrow (each
genotype, n = 1).
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Red Blood Cell Numbers are Elevated in
PRNPTer/Ter Animals
To analyze whether reduced levels or complete lack of PrPC
influences the cellular or chemical composition of the blood,
we performed hematological and clinical chemistry analyses of
PRNPTer/Ter, PRNP+/Ter and PRNP+/+ goat kids between 3 and
4 weeks of age.
Clinical chemistry revealed a slightly, but significantly, lower
magnesium level and an increased creatine level in PRNPTer/Ter
animals compared to PRNP+/+, both well within the normal
reference range (see Supplementary Table 2).
The number of RBCs was increased in PRNPTer/Ter goat
kids (Table 1 and Figure 2A) as compared to the PRNP+/+
and PRNP+/Ter groups. Mean cell volume of the RBCs (MCV)
was not significantly different between the groups, although the
distribution of values suggested a clear tendency of lower MCV
in the PRNPTer/Ter animals compared to the PRNP+/+ and
PRNP+/Ter groups (Table 1 and Figure 2B).
The groups did not differ in hematocrit (HCT) values
(Table 1), suggesting that the reduced RBC volume was
compensated by an increased number of RBCs or vice
versa. To investigate if differences in iron uptake and
metabolism could have any influence on RBC number
and MCV we investigated the iron levels in blood serum.
However, iron levels did not differ between the genotypes
(Figure 2C).
TABLE 1 | Hematology results.
Reference range Median P-values
A: PRNP+/+ B: PRNP+/Ter C: PRNPTer/Ter A vs. B B vs. C A vs. C
White blood cells (× 109/l) 4–16 7.5 7.4 8.65 0.75 0.73 0.34
Red blood cells (× 1012/l) 8–18 10.61 10.58 11.78 0.8 0.006 0.007
Hemoglobin (g/l) 75–125 66 67 67 0.51 0.87 0.82
Hematocrit (l/l) 0.22–0.38 0.25 0.26 0.25 0.51 0.8 0.92
Mean corpuscular volume (fl) 16–25 23.65 24.3 21.6 0.67 0.051 0.08
Mean corpuscular hemoglobin content (g/l) 320–370 267.5 262 270 0.51 0.11 0.058
Rdw (%) 23–35 53.8 53.1 52.2 0.99 0.62 0.76
Neutrophils (× 109/l) 1.5–8 2.25 2.35 3.75 0.35 0.33 0.068
Lymphocytes (× 109/l) 2–9 4.8 4.35 4.35 0.28 0.75 0.6
Monocytes (× 109/l) 0–0.5 0.35 0.45 0.45 0.028 0.91 0.08
P-values < 0.05 are shown in bold.
FIGURE 2 | Selected hematology parameters and serum iron
values from 3 to 4 weeks old goat kids. Dot plots showing (A)
the number of RBCs, (B) the RBC mean cell volume, (C) the serum
iron levels, and (D) absolute number of neutrophils in PRNPTer/Ter
(n = 8), PRNP+/Ter (n = 16), and PNRP+/+ (n = 24) animals. * and **
indicate P < 0.05.
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In blood smears from PRNPTer/Ter (n = 8) and PRNP+/+
(n = 24) animals a marked poikilocytosis was observed, as
expected in young kids. The neutrophil granulocytes weremature
and showed no signs of left shift in any of the genotypes. No
reticulocytes were present in any of the smears (data not shown).
Within the leukocyte populations, there was a tendency
of a higher neutrophil count in the PRNPTer/Ter animals as
well as an increase in the monocyte number in PRNPTer/Ter
and PRNP+/Ter animals compared to the PRNP+/+ group
(Table 1 and Figure 2D). The majority of the hematology values
were within the general reference ranges for goats, except
mean cell hemoglobin content (MCHC), red cell distribution
width (RDW), and hemoglobin, where values fell below the
presented reference range in all genotypes. However, breed-
specific reference ranges were not available, and since these low
values were present in all groups they would most likely be within
normal ranges for rapidly growing goat kids of this breed.
Observing that PrPC was highly expressed in a range of
immune cells in normal goats we investigated whether lack
of PrPC expression influenced the numbers of these cells in
peripheral blood. The relative numbers of monocytes (CD14+), B
cells (B-B2+), T cells (CD3+) as well as the gamma-delta (WC1+)
and CD8+ subsets of T cells were quantified by flow cytometry
(Figure 3). CD4+ T-cell labeling was excluded from the study
due tomethodological problems. No differences in numbers were
revealed for any of these leukocyte subsets between the PRNP+/+
and PRNPTer/Ter genotypes.
Morphological Analysis of Bone Marrow
To investigate whether the observed difference in hematological
profile could be reflected by morphological changes in bone
marrow, smears, and imprints of bone marrow from 3 months
old PRNP+/+ (n = 1) and PRNPTer/Ter (n = 1) goat
kids were analyzed. However, there were no differences in
myeloid/erythroid ratio between the two genotypes, and the
precursor cells had a normal appearance. In addition, there
was no observable difference in degree of apoptosis (data
not shown). Altogether, no evident morphological changes
FIGURE 3 | Relative immune cell population sizes in 3–4 weeks old goat kids. Flow cytometric analysis of (A) CD3+ T cells, (B) CD8+ T cells, (C) γδ T cells,
(D) B cells, and (E) CD14+ monocytes out of the total PBMC population.
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were found within the bone marrow of the PRNPTer/Ter
goat kid.
Monocyte Phagocytosis and T-cell Proliferation
Appear Unaltered in PRNPTer/Ter Animals
To determine whether PrPC might have a functional impact on
white blood cells, we performed phagocytosis and proliferation
studies to assess two major functional properties of leukocytes.
Positively selected CD14+ monocytes from peripheral blood
were cultured for 24 h to stabilize cells following isolation,
and supplemented with GM-CSF to activate the cells and
prevent apoptosis (Bratton et al., 1995). The resulting short-
term activated monocytes were incubated with latex beads,
bacteria (Escherichia coli), or zymosan-covered yeast cells
(Saccharomyces cerevisiae) for 30min. Fluorescence and confocal
microscopy of cytospots confirmed the cellular uptake of
particles (Figures 4A–C and data not shown). A majority of
the monocytes were CD68+, consistent with monocytes or
macrophages as previously described (Fadini et al., 2013).
These cells had numerous vacuoles in the cytoplasm and a
round to bean-shaped nucleus. All particle types were efficiently
phagocytized by activated monocytes (Figures 4D,E). When
comparing activatedmonocytes from PRNP+/+ and PRNPTer/Ter
goats by flow cytometry, we detected no significant differences
between the genotypes in the proportions of cells that had
taken up fluorescent particles, for none of the particle types
(Figures 4 F–H). There was also no significant difference in the
numbers of particles per cell measured as median fluorescent
intensity of positive cells; or in the case of latex beads, the number
of cells that had engulfed 2 beads ormore (Figure 4E and data not
shown).
To investigate if PrPC expression could be involved in cellular
proliferation, we stimulated PBMCs in vitro using the mitogen
Con A or the cytokines IL-2 or IL-15 to cover proliferation
of T cells and NK cells/innate lymphocytes (Figure 5). The
cell cultures proliferated well in response to these stimuli, but
no significant differences between the groups were observed,
although a slightly higher median response of cells from the
PRNPTer/Ter group was noted for all stimulations.
Collectively, these results suggest that loss of PrPC does not
have any major influence on the phagocytic ability of activated
monocytes or the proliferative capacity of T or NK cells in vitro.
Discussion
The PrPC is phylogenetically conserved and widely present in
vertebrates (Harrison et al., 2010), pointing to an essential role
for the organism. Non-transgenic animals naturally devoid of
PrPC, which has not been reported until recently (Benestad
et al., 2012), could provide essential information regarding PrPC
physiology and function. In the present study we have observed
that such PRNPTer/Ter goats present with hematological changes,
although without morphological changes in the bone marrow or
alterations in major immune parameters.
By investigating complete blood counts of 3–4 weeks
old goat kids we demonstrated that PRNPTer/Ter animals
had a significantly higher number of RBC compared to
matched PRNP+/+ controls. Tendencies of changes in other
hematological values were also observed, such as lowered MCV
and increased amounts of neutrophil granulocytes. These results
are strikingly similar to the hematological observations in 10
months old PrPC KO cattle (Richt et al., 2007), which had
increased numbers of RBC, WBC, and neutrophil granulocytes,
and lowered MCV and MCH. The authors of the study
questioned if the gene cassette used in the transgenic procedure
rather than the absence of PrPC per se could have caused the
observed differences. Our findings in naturally mutated animals
strengthen the likelihood that PrPC loss may physiologically
affect RBC parameters and neutrophil numbers in young
ruminants. Preliminary hematology results from adult goats have
revealed no differences between the genotypes in any of the
hematological values (unpublished results).
Several experimental approaches have shown that phenotypes
related to loss of PrPC are only clearly evident under various
stressful conditions, such as tissue damage, infection, or anemia
(Zivny et al., 2008; Gourdain et al., 2012). Likewise, it could
be speculated that the increased demand for cell proliferation
in the bone marrow during growth represents a physiological
stress which reveals an otherwise cryptic phenotype caused by
loss of PrPC. Accordingly; a relatively subtle impact would not
be observable in adult goats with lower bone marrow activity.
Mice lacking PrPC have been reported to be in a chronic
state of systemic iron deficiency, ascribed to inefficient uptake
and transport into the blood stream, as well as inefficient
uptake in various recipient cells, which could be rescued by the
reintroduction of PrPC (Singh et al., 2009). To rule out any
impact of iron deficiency on the erythroid lineage we analyzed
iron levels in all investigated animals. Although a smaller cell
volume could be a result of an iron deficiency, we did not detect
any difference in circulating iron levels that would support a state
of systemic iron deficiency in PRNPTer/Ter animals.
Studies in PrPC KO mice have suggested a possible influence
of PrPC on long-term hematopoietic stem cells (LT-HSCs),
as these cells showed reduced regenerative capacity when
undergoing serial transplantations (Zhang et al., 2006). However,
before the interventions, mice were normal with respect to blood
cell levels and presence of cell lineage profiles in the bone
marrow. In the present study, we did not observe morphological
evidence of bone marrow impairment, as apoptosis rate and
myeloid/erythroid ratio was found similar in a PRNPTer/Ter
animal compared to a normal control. More comprehensive
and cell-specific investigations are however needed to clarify
whether there are changes in bone marrow cellular composition
in growing PRNPTer/Ter kids, and further studies are needed to
reach a final conclusion regarding possible differences between
genotypes with respect to stem cell phenotypes in animals, both
under normal and stressful conditions.
We detected high PrPC expression in peripheral blood
mononuclear leukocytes but not granulocytes of PRNP+/+
animals, similar to previous reports that have led to a particular
interest for PrPC functions in immune cells, several of which
have suggested PrPC involvement in immune cell functions
(Dodelet and Cashman, 1998; Barclay et al., 1999; Durig et al.,
2000; Holada and Vostal, 2000; Herrmann et al., 2001; Halliday
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FIGURE 4 | Phagocytosis assays. Cytospots confirmed the cellular uptake
of (A) latex beads (green fluorescence), (B) E. coli (red fluorescence), and (C)
Zymosan (red fluorescence) in activated monocytes. Additional staining for
nuclei (blue) and CD68 (A red, B and C green). (D) Gating of live cells based
on FS and SS characteristics in flow cytometry. (E) Particle uptake in
PRNPTer/Ter and PRNP+/+ cells based on the results from two
representative animals. Medium only was used as control. Gates indicate
particle-containing cells, and in the case of latex beads, also gates for cells
that had engulfed 2 particles or more (F–H) Compiled results of all animals
showing percentage of monocytes containing (F) latex beads, (G) Zymosan
and (H) E. coli, as measured by flow cytometry. For each assay, n = 8,
except PRNPTer/Ter E. coli where n = 7.
et al., 2005; Dassanayake et al., 2012). Hematological analysis
suggested a higher count of neutrophil granulocytes and possibly
monocytes in PRNPTer/Ter kids, while flow cytometric analyses
did not confirm any difference in CD14+ monocyte numbers,
and relative numbers of other major circulating mononuclear cell
subsets also appeared unaffected by PrPC loss. Similar results,
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FIGURE 5 | Lymphocyte proliferation test. Proliferation of T cells after 72 h stimulation with (A) Con A, (B) IL-2, and (C) IL-15, measured as beta emission
following DNA incorporation of tritiated thymidine (net CPM = sample CPM − control CPM). In all cases n = 8.
including increased neutrophil counts, have been found in KO
cattle, although a tendency of more numerous γδ T cells in a
group of four PrPC cattle compared to four WT cattle, was found
(Richt et al., 2007). Few similar studies have been done in murine
PrPC KO models but in a double KO, namely PrPC and Doppel
KO mice, no alterations in the immune cell populations were
noted (Genoud et al., 2004). Seen together these results indicate
that mechanisms that regulate the levels of immune cells in the
blood are largely independent of PrPC.
It has been shown that PrPC is expressed in regulatory
and memory T cells (Li et al., 2001), and that levels of PrPC
increase during T-cell proliferation (Cashman et al., 1990;
Mabbott et al., 1997). Furthermore, T cells lacking PrPC display
reduced proliferation rates (Mabbott et al., 1997). Here, we
stimulated PBMCs in vitro with mitogen or cytokines to assess
alternative proliferation pathways but detected no difference in
the proliferation rates between the genotypes. This correlates
with the findings in transgenic cattle (Richt et al., 2007).
Nevertheless, a slightly higher mean response in the PRNPTer/Ter
group consistent through all stimulations could suggest that
proliferative differences may be present in more restricted
lymphocyte subsets. Furthermore, we quantified the uptake of
bacteria, yeast and latex particles by activated bloodmonocytes in
order to approach different activation pathways of phagocytosis
(Flannagan et al., 2012). We did not find that PrPC deficiency
had any influence on the proportion or efficiency of monocytes
to phagocytize any of these particle types. Earlier studies on
phagocytosis have been performed with cells from PrPC KO
mice and have given conflicting results. In an in vitro study of
phagocytosis of E. coli by bonemarrow-derivedmacrophages, the
activity was enhanced in cells from PrPC KO mice (Wang et al.,
2014). Conversely, macrophages from PrPC KOmice were shown
to phagocytize latex beads at a lower rate than macrophages from
WTmice (Uraki et al., 2010). In another study, De Almeida et al.
(2005) found that PrPC is a negative modulator of phagocytosis,
as peritoneal macrophages from PrPC KO mice phagocytized
apoptotic cells at a higher rate than cells from WT mice in vitro
and in vivo, a result confirmed by two different mouse strains.
The results from the latter study have later been linked to
polymorphisms in PrPC flanking genes involved in phagocytosis,
rather than the loss of PrPC in itself (Nuvolone et al., 2013),
and similar concerns might be raised regarding other reports
on PrPC functions from PrPC KO models. Our results from
naturally PrPC-devoid animals are not in support of a principal
mechanistic role of the prion protein neither in lymphocyte
proliferation nor in phagocytosis.
In summary, this study showed that naturally occurring PrPC-
deficient goat kids displayed a generally healthy constitution,
moderate shifts in red blood cell and possibly granulocytic
cell lineages but not in other major circulating hematopoietic
cells. No impairment of major immune cell functions was
detected. These results point toward a role for PrPC related
to maturation and release of selected cell lineages from the
bone marrow, and underscore previous observations that PrPC
loss appears to have limited physiological or pathological
consequences for the animal, at least under conventional living
conditions and in the absence of significant stressors. The present
natural goat model offers a unique opportunity to study the
function of PrPC in and ex vivo without the confounding
factors of genetic engineering, which may hopefully help to
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shed light on the elusive nature of this protein and its related
diseases.
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